Log in to save to my catalogue

Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients a...

Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3076847971

Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy

About this item

Full title

Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy

Publisher

Cairo: Springer Nature B.V

Journal title

The Egyptian journal of medical human genetics, 2024-07, Vol.25 (1), p.80

Language

English

Formats

Publication information

Publisher

Cairo: Springer Nature B.V

More information

Scope and Contents

Contents

BackgroundDiabetic nephropathy (DN) is a frequent and long-lasting microvascular consequence that has an established connection with diabetes. It serves as the primary etiological agent of end-stage renal disease, a critical renal disorder that develops on a worldwide level. The molecular pathophysiology of DN is multifactorial, such as transformin...

Alternative Titles

Full title

Evaluation of serum MicroRNA 21, MicroRNA 192 and serum TGFβ1 in type 2 diabetes mellitus patients and their relation to diabetic nephropathy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3076847971

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3076847971

Other Identifiers

ISSN

1110-8630

E-ISSN

2090-2441

DOI

10.1186/s43042-024-00544-z

How to access this item